Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Phase Ib dose-expansion study of ociperlimab (OCI) + tislelizumab (TIS) with chemotherapy (chemo) in patients (pts) with metastatic squamous (sq) and non-squamous (non-sq) non-small cell lung cancer (NSCLC) | ANNALS OF ONCOLOGY |